Contributed by:
This grant was established in 2015.
Research Grants Supported
Dr. Thomas Cunningham, 2023
MRC Prion Unit at UCL, Institute of Prion Diseases
Generation of Humanised STX6 Overexpression Mice to Study Prion Disease Genetic Risk and as a Model for Therapeutic Intervention
Joaquín Castilla, PhD, 2022
Basque Foundation for Science, Bilbao, Spain
"Development and characterization of the fastest animal model able to propagate GSS prions faithfully"
Holger Wille, PhD, 2021
University of Alberta, Centre for Prions and Protein Folding Diseases
"Evaluating passive immunotherapy in prion-infected transgenic mice expressing human PrP"
Qingzhong Kong, PhD, 2020
Case Western Reserve University
“The RAP approach for effective prevention and treatment of prion diseases”
Steven E. Arnold, MD, 2019
Assessing long-term stability of cerebrospinal fluid PrP levels in genetic prion disease mutation carriers
Professor of Neurology, Harvard Medical School; and Translational Neurology Head of the Interdisciplinary Brain Center, Massachusetts General Hospital
Leonardo Cortez, Ph.D., 2018
Isolation and Strain-Specific Characterization of Pathogenic CJD Prion Particles
Centre for Prions and Protein Folding Diseases, University of Alberta, Edmonton, Alberta, Canada
Stéphane Haik, M.D., Ph.D., 2017
Worms: A Novel Genetic Model for Therapeutic Research in Prion Disease
Alzheimer’s and Prion Diseases Lab at the Brain & Spine Institute (ICM) of the Salpêtrière Hospital, Sorbonne Université,
Paris, France
Roberto Chiesa, Ph.D., 2016
A New Anti-Prion Compound that Reduces PrPc levels and Inhibits PrPsc Replication
[Awaiting permission to release from Dr. Chiesa.]
Istituto di Ricerche Farmacologiche Mario Negri
Milano, Italy
Julie Moreno, Ph.D., 2015
The Role of Cellular Chaperones and the Unfolded Protein Response in Gerstmann-Sträussler-Scheinker Syndrome
Prion Research Center, Colorado State University
Fort Collins, Colorado